https://www.selleckchem.com/pr....oducts/yap-tead-inhi
Vasomotor symptoms (VMS) (hot flashes and night sweats) affect most women over the menopause transition. Comparing the safety and effectiveness of treatments for vasomotor symptoms is limited by the use of inconsistent outcome measures, and uncertainty as to which outcomes are most important to symptomatic women. To address this, we have developed a Core Outcome Set (COS) for use in clinical trials of treatments for VMS. We systematically reviewed the primary outcomes measured in randomized controlled trials of t
Like
Comment
Share
